Where does Delphinus Medical Technologies, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Delphinus Medical Technologies, Inc. ranks #11,990 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Delphinus Medical Technologies, Inc. hold?

Delphinus Medical Technologies, Inc. holds 25 US utility patents granted between 2015 and 2025, spanning 5 technology areas.

What is Delphinus Medical Technologies, Inc.'s Innovation Score?

Delphinus Medical Technologies, Inc. has an Innovation Score of 33.8 out of 100 (46th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Delphinus Medical Technologies, Inc. focus on?

Delphinus Medical Technologies, Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 25 patents, ranking #733 of 7,127 assignees active in that subclass. Grants appear in 5 CPC subclasses total.

Is Delphinus Medical Technologies, Inc.'s patent grant rate increasing or decreasing?

Delphinus Medical Technologies, Inc.'s recent grant velocity is -29% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Delphinus Medical Technologies, Inc.'s patents?

Delphinus Medical Technologies, Inc.'s patents average 19.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Delphinus Medical Technologies, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Delphinus Medical Technologies, Inc.

USPTO PatentsView assignee record - 25 granted patents across 5 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Delphinus ranks #11,990 of 49,997 tracked US assignees by granted-patent volume, with 25 patents across 5 technology areas.

#11,990
of 49,997 US assignees by volume: 46th percentile
by Innovation Score (33.8/100): 19.4
avg claims per patent: -29%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R11990 · US Corporation #11,990 · 25 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DOWN · BOOK-FULL

GRANTS-SMALL 25 grants
UPPER-Q #11,990/49,997
PHOTO-FINISH DataRobot
CPC-NARROW A61B · 5 areas
INNOV-THIN 33.8/100
CLAIMS-RICH 19.4 claims/avg
TYPE-USCORP US Corporation
VEL-DOWN -29% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: DataRobot, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Delphinus’s 33.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 11.3 pts (33%) Velocity 3.0 pts (9%) Breadth 7.9 pts (23%) Claim depth 11.6 pts (34%)

Qualcomm Incorporated · highest

85
HCT Group Holdings · near

34
Delphinus Medical · this assignee

34
Institut Pasteur DE… · near

34
Kingsway Enterprises… · near

34
Aesculap Implant… · near

34
3D Lighting… · lowest

7

What this shows Delphinus's Innovation Score is 33.8/100 (46th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Delphinus?

Each dot is one of Delphinus’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Delphinus’s own 19.4 claims/patent is ABOVE the 17.8 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Delphinus vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Delphinus's grants concentrate

Delphinus Medical Technologies, Inc. is a focused PatentsView assignee: 5 CPC subclasses with 100% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2019 (6 grants) versus a trough of 1 in 2020. By volume, Delphinus sits between DataRobot, Inc. and Equos Research Co., Ltd..

Delphinus's three-year grant acceleration

Delphinus Medical Technologies, Inc. shows 5 grants in 2022–2024 against only 11 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Datarobot

25
De Beers UK

25
Deep Isolation

25
Dejana Truck and…

25
Diehl Defence & KG

25
Ecole Centrale DE…

25
EI

25
Equos Research

25
Delphinus Medical ◀

25

What this shows Delphinus holds 25 patents at rank #11,993, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Delphinus

By rank, the assignees closest to #11,993 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Delphinus's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Delphinus, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), Delphinus ranks #733 of 7,127 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (34 here).

Kingsway Enterprises (UK) Limited 34 Institut Pasteur DE Lille 34 HCT Group Holdings Limited 34 Aesculap Implant Systems, LLC 34

Delphinus's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

34 46th percentile higher than 46% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Delphinus Medical Technologies, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	3	12.0%
2017	2	8.0%
2018	3	12.0%
2019	6	24.0%
2020	1	4.0%
2021	4	16.0%
2022	4	16.0%
2024	1	4.0%
2025partial year	1	4.0%

Which technologies does Delphinus Medical Technologies, Inc. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 25

G06T - Image Data Processing OR Generation, IN General 14

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 3

G06V - Image OR Video Recognition OR Understanding 1

G06F - Electric Digital Data Processing 1

Top 5 of 5 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Delphinus Medical Technologies, Inc.'s patent record in context - here's where to go next.

Delphinus Medical Technologies, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 100% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #11,990 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Delphinus Medical Technologies, Inc. against DataRobot, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 33.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.